Personalized medicine

Dr. Amit Zabtani, an orthopedic surgeon at UCLA and cofounder and CMO of CustoMED, says the company uses 3D printing to create patient-specific instruments based on an individual’s anatomy, enabling more precise positioning during surgery.

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.

Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, says Sky Labs CEO Jack Byunghwan Lee.

Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.

The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.

Developed by Cancer Institute NSW, the multi-data-trained tool aims to educate people over 40 about their cancer risks.

The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.

Early results show 70% accuracy of AI-assisted detection of unexplained male infertility using Asian IVF data.

The model also calculates biological ageing and survival patterns to support personalized health risk management.